1. Home
  2. ATHA vs MTEK Comparison

ATHA vs MTEK Comparison

Compare ATHA & MTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATHA
  • MTEK
  • Stock Information
  • Founded
  • ATHA 2011
  • MTEK 2008
  • Country
  • ATHA United States
  • MTEK Israel
  • Employees
  • ATHA N/A
  • MTEK N/A
  • Industry
  • ATHA Medicinal Chemicals and Botanical Products
  • MTEK
  • Sector
  • ATHA Health Care
  • MTEK
  • Exchange
  • ATHA Nasdaq
  • MTEK Nasdaq
  • Market Cap
  • ATHA 21.0M
  • MTEK 21.7M
  • IPO Year
  • ATHA 2020
  • MTEK 2022
  • Fundamental
  • Price
  • ATHA $0.43
  • MTEK $2.58
  • Analyst Decision
  • ATHA Buy
  • MTEK
  • Analyst Count
  • ATHA 4
  • MTEK 0
  • Target Price
  • ATHA $11.25
  • MTEK N/A
  • AVG Volume (30 Days)
  • ATHA 210.5K
  • MTEK 88.4K
  • Earning Date
  • ATHA 03-04-2025
  • MTEK 03-20-2025
  • Dividend Yield
  • ATHA N/A
  • MTEK N/A
  • EPS Growth
  • ATHA N/A
  • MTEK N/A
  • EPS
  • ATHA N/A
  • MTEK N/A
  • Revenue
  • ATHA N/A
  • MTEK $6,967,508.00
  • Revenue This Year
  • ATHA N/A
  • MTEK N/A
  • Revenue Next Year
  • ATHA N/A
  • MTEK N/A
  • P/E Ratio
  • ATHA N/A
  • MTEK N/A
  • Revenue Growth
  • ATHA N/A
  • MTEK 246.50
  • 52 Week Low
  • ATHA $0.41
  • MTEK $1.13
  • 52 Week High
  • ATHA $4.21
  • MTEK $6.47
  • Technical
  • Relative Strength Index (RSI)
  • ATHA 34.62
  • MTEK 38.10
  • Support Level
  • ATHA $0.42
  • MTEK $2.82
  • Resistance Level
  • ATHA $0.46
  • MTEK $2.86
  • Average True Range (ATR)
  • ATHA 0.04
  • MTEK 0.29
  • MACD
  • ATHA -0.00
  • MTEK -0.01
  • Stochastic Oscillator
  • ATHA 10.85
  • MTEK 14.82

About ATHA Athira Pharma Inc.

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

About MTEK Maris-Tech Ltd.

Maris Tech Ltd is a provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.

Share on Social Networks: